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Introduction. Herpes simplex esophagitis is well recognized in immunosuppressed subjects, but it is infrequent in immuno-
competent patients. We present a case of HSE in a 53-year-old healthy man. Materials and Methods. The patient was admitted
with dysphagia, odynophagia, and retrosternal chest pain. An esophagogastroduodenoscopy revealed minute erosive area in
distal esophagus and biopsies conﬁrmed esophagitis and ﬁndings characteristic of Herpes Simplex Virus infection. Results.
The patients was treated with high dose of protonpump inhibitor, sucralfate, and acyclovir, orally, with rapid resolution of
symptoms. Discussion. HSV type I is the second most common cause of infectious esophagitis. The majority of symptomatic
immunocompetent patients with HSE will present with an acute onset of esophagitis. Endoscopic biopsies from the ulcer edges
shouldbeobtainedforbothhistopathologyandviralculture.Inimmunocompetenthost,HSEisgenerallyaself-limitedcondition.
Conclusions. HSE should be suspected in case of esophagitis without evident cause, even if the patient is immunocompetent. When
the diagnosis of HSE is conﬁrmed, careful history and assessment for an immune disorder such as HIV infection is crucial, to look
for underlying immune deﬁciency.
Copyright © 2009 G. Geraci et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Herpes simplex virus (HSV) has been recognized with
increased frequency as an opportunistic invader of the
esophagus in immunosuppressed, immunocompromised, or
severely ill subjects (reactivation or primary infection).
Herpes simples esophagitis (HSE) may occasionally
occur in otherwise healthy and immunocompetent patients
who had no underlying immunologic problems [1, 2].
We herein present a case of immunocompetent adult
with HSE who had a dramatic response to acyclovir therapy.
2.CaseReport
A 58-year-old man presented to our endoscopic unit for 1
month history of moderate dysphagia for liquids and solids,
odynophagia, and retrosternal chest pain.
He had no signiﬁcant medical or surgical history, and he
denied abuse of tobacco or alcohol.
Clinical history and physical examination were unre-
markable.
Esophagogastroduodenoscopy (EGD) was performed
and revealed small erosion (6mm) in the distal esophagus
(Figures 1(a) and 1(b)). The rest of the endoscopic examina-
tion was normal. Multiple esophageal biopsies were obtained
and sent for histopathologic examination.
Histopathology from the esophageal biopsy specimens
was consistent acute, severe inﬂammation, multinucleated
giant cells with nuclear molding and nuclear chromatin
with a groundglass appearance, ﬁndings characteristic of
herpes virus infection (Papanicolaou’s stain, orig. mag. ×100
and ×600), typical of HSV type 1 infection (Figures 1(c)
and 1(d)). Subsequent polymerase chain reaction (PCR)
conﬁrmed the diagnosis of HSE.
After diagnostic conﬁrmation and negativity of HIV
testing, the patients started treatment with high dose of
proton-pump inhibitor (80mg a day), sucralfate, and acy-
clovir 800mg daily for 5 days, orally, with rapid resolution of
symptoms and complete “restitutio ad integrum” at EGD.
However, he had no risk factors for HIV infection and
no personal history of HSV infection or Herpes Zoster
reactivation. 1-year followup clinical and at EGD is negative.2 Diagnostic and Therapeutic Endoscopy
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Figure 1: (a) Endoscopic (b) and histological ((c) [×100], (d) [600×]) appearance.
3. Discussion
After candidiasis, HSV type I is the second most common
cause of infectious esophagitis. HSE is most commonly seen
in immunocompromised patients with AIDS (1% of all
patients with AIDS and 1.8%–4.3% of patients with AIDS at
autopsy) [3], an underlying malignancy, a debilitating illness
in patients who have been treated with radiation, steroids, or
antiblastic chemotherapy.
HSE in immunocompetent hosts is rare and it may
represent either a primary disease or reactivation of a latent
infection.
Typically, the patient is a young (<40 years in 78% of
cases), healthy male who presents with acute odynopha-
gia, dysphagia, or heartburn, with or without prodromal
symptoms (fever, pharyngitis, respiratory symptoms) or oral
lesions. Prior exposure to a family member with possible
HSV lesions has been reported in about 20% of cases [2, 4].
Most symptomatic immunocompetent patients with
HSE will present with an acute onset of esophageal com-
plaints, but a subset of patients (24%) will present with
a prodrome of symptoms, including odynophagia (76% of
patients), fever (44%–63%), and respiratory manifestations
(sorethroath in 23%). Other common complaints associated
with HSE may include retrosternal pain (60%), heartburn
(50%), dysphagia (21%), myalgia (21%), and poor oral
intake (13%) [2]( Table 1).
Oral manifestations (Herpes labialis) may precede the
onsetofodynophagiaby1–4days,coincidewithitordevelop
1–5 days afterward [2].
HSE has characteristic endoscopic appearances (the
distal or mid-esophagus is commonly involved in more than
50% of cases, although in 26% of cases the entire esophagus
is aﬀected) [2]: in the early stage, vesicles are seen, which
then slough to form discrete, circumscribed ulcers with
raised edges; the mucosa is friable (84%). These lesions have
punched-out or volcano-like appearances. Cobblestoning
can be seen due to clustering of these lesions. Exudate is
present in a majority of cases [5]. Mucosal necrosis is seen
in the late stage [6]( Table 2).
In case of esophageal erosions or if HSE is clinically sus-
pected, biopsies from the ulcer edges should be obtained for
both histopathology and viral culture [7]. Virus isolation by
cell culture has traditionally been considered the diagnostic
“gold standard” for HSV infection.
The characteristic histologic appearance is the presence
of multinucleated giant cells with eosinophilic intranuclear
inclusions, called Cowdry type A intranuclear inclusions and
nuclear chromatin with a groundglass appearance.
In recent years, HSV DNA PCR is considered the most
sensitive, cost eﬀective, rapid, and easiest diagnostic tool of
HSV infection [8].
Serology is of limited value as a majority of healthy
individuals will have a prior exposure to HSV, unless there
is seroconversion.
Antiviral therapy, in the early stage, is advisable to
hasten recovery and to rapidly achieve symptomatic relief
[9]; treatment with the nucleoside analog acyclovir has
been shown to be eﬀective for HSE. The duration ofDiagnostic and Therapeutic Endoscopy 3
Table 1: Symptoms [2].
Acute onset of
esophagitis without
prodrome
Retrosternal pain
76% dysphagia
heartburn
Prodrome 24%
Odynophagia 76%
Fever 44%–63%
Sore throath 23%
Myalgia 21%
Poor oral intake 13%
Table 2: Endoscopic appearance [2, 5, 6].
Localization Distal or mid-esophagus >50%
Entire esophagus 26%
Early stage
Exudate 90%
Friable mucosa 84%
Vesicles 80%
Circumscribed ulcers 40%
Cobblestoning (lesions
conﬂuence)
30%
Late stage Necrosis 40%
illness ranges from 4 to 9 days in those receiving antiviral
therapy compared with 10 to 17 days in those receiving
symptomatic treatment alone. Although HSE is noted to
be a self-limited condition, cases of immunocompetent
patients experiencing signiﬁcant complications, including
gastrointestinal bleeding and esophageal perforation, have
been reported [10]. Recurrence of this condition is rare.
4. Conclusions
HSE should be suspected in otherwise healthy subjects (irre-
spective of age) with symptoms (odynophagia, heartburn)
suggestive of esophagitis without obvious cause, particularly
in patients with ulcerations in distal or mid-distal esophagus
atendoscopy.Inthesecases,endoscopicbiopsyfromtheedge
of ulcers should be examined microscopically and submitted
for viral culture.
When HSE is incountered, a careful history and assess-
ment for an immune disorder such as HIV infection is
crucial, to look for possible underlying pathology.
HSE in the immunocompetent host is self-limiting, but
antiviral therapy may shorten the illness if started early.
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